Upon initiation of GC treatment in pregnant patients with RA, median CRP values of 13 mg/L decreased to normal levels (P = 0.04) (Fig. 2b), and DAS28-CRP dropped from 3.95 to 2.45, indicating inactive disease. The gene discussed is CRP; the disease is rheumatoid arthritis.